| Goodwill and intangible assets |
Note 6 – Goodwill and intangible assets
Goodwill
The Company’s net carrying amount of goodwill is in the
Clinical Laboratory Services segment and is $7,452 as of January 31, 2021 and 2020.
Intangible assets
The Company’s change in the net carrying amount of intangible
assets, all in the Life Sciences Products segment is as follows:
| |
|
Gross |
|
|
Accumulated Amortization |
|
|
Net |
|
| July 31, 2020 |
|
$ |
27,686 |
|
|
$ |
(27,148 |
) |
|
$ |
538 |
|
| Amortization expense |
|
|
- |
|
|
|
(151 |
) |
|
|
(151 |
) |
| Foreign currency translation |
|
|
168 |
|
|
|
(162 |
) |
|
|
6 |
|
| January 31, 2021 |
|
$ |
27,854 |
|
|
$ |
(27,461 |
) |
|
$ |
393 |
|
Intangible assets, all finite-lived, consist of the following:
| |
|
January 31, 2021 |
|
|
July 31, 2020 |
|
| |
|
Gross |
|
|
Accumulated
Amortization |
|
|
Net |
|
|
Gross |
|
|
Accumulated
Amortization |
|
|
Net |
|
| Patents |
|
$ |
11,027 |
|
|
$ |
(11,023 |
) |
|
$ |
4 |
|
|
$ |
11,027 |
|
|
|
(11,014 |
) |
|
$ |
13 |
|
| Customer relationships |
|
|
12,095 |
|
|
|
(11,706 |
) |
|
|
389 |
|
|
|
12,003 |
|
|
|
(11,478 |
) |
|
|
525 |
|
| Website and acquired content |
|
|
1,028 |
|
|
|
(1,028 |
) |
|
|
- |
|
|
|
1,022 |
|
|
|
(1,022 |
) |
|
|
- |
|
| Licensed technology and other |
|
|
492 |
|
|
|
(492 |
) |
|
|
- |
|
|
|
483 |
|
|
|
(483 |
) |
|
|
- |
|
| Trademarks |
|
|
3,212 |
|
|
|
(3,212 |
) |
|
|
- |
|
|
|
3,151 |
|
|
|
(3,151 |
) |
|
|
- |
|
| Total |
|
$ |
27,854 |
|
|
$ |
(27,461 |
) |
|
$ |
393 |
|
|
$ |
27,686 |
|
|
|
(27,148 |
) |
|
$ |
538 |
|
| At January 31, 2021, information with respect to acquired intangibles is as follows: |
|
Useful life assigned |
|
Weighted average
remaining useful life |
| Customer relationships |
|
8 -15 years |
|
1 year |
At January 31, 2021, the weighted average remaining useful life
of all intangible assets was approximately two years.
|